Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...

Exciting potential in Korro Bio, Inc.'s non-viral gene editing platform as they enter clinical trials with a strong cash ...

That's why we created this helpful guide on vitamin B12 to help you learn more about vitamin B12 deficiency, supplements and injections. Vitamin B12 contains cobalt, hence its name, cobalamin.

Rare genetic disorders affect approximately 1 in 10 people worldwide, meaning over 350 million individuals are living with these conditions. Despite their rarity, there are over 7,000 identified rare ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Krystal Biotech (KRYS – Research Report) yesterday and set a price ...

Protein deficiency indicates a lack of protein in the body. It is a rare problem in developed countries like the United States, where there are sufficient food sources. Most of the U.S. population ...

KB407 is being developed in a phase I study for the treatment of cystic fibrosis (CF), while KB408 is being developed in a phase I study for treating alpha-1 antitrypsin deficiency (AATD).

12 following the announcement of the news. KB407 is being developed in a phase I study for the treatment of cystic fibrosis (CF), while KB408 is being developed in a phase I study for treating alpha-1 ...

If approved, garadacimab will be the first and only once-monthly treatment inhibiting factor XIIa to prevent attacks in HAE patients – a community CSL has been serving for more than 40 years MARBURG, ...